Despite the impact of the pandemic on cancer care, Perjeta grew 17% to CHF 2.9 billion ($3.2 billion) in the first nine months of 2020, now just fractionally behind Herceptin which declined 31% to ...

Roche's Perjeta has been launched today in the UK for use in women with HER2-positive breast cancer before surgery – but, as with many new cancer drugs, access to treatment is uncertain. Trials ...

Rheumatoid arthritis drugs fight pain and prevent joint damage. See a full list of RA medications, including NSAIDs, DMARDs, immunosuppressants, and others.